Differential effect of vitamin D on NOD2- and TLR-induced cytokines in Crohn's disease

Mucosal Immunology

Volumn 7, Issue 6, 2014, Pages 1405-1415

  Dionne, S ^a   Calderon, M R ^b   White, J H ^b   Memari, B ^b   Elimrani, I ^a   Adelson, B ^a   Piccirillo, C ^a   Seidman, E G ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; I KAPPA B ALPHA; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 23; INTERLEUKIN 23P40; MITOGEN ACTIVATED PROTEIN KINASE; MURAMYL DIPEPTIDE; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IMMUNOLOGIC FACTOR; NOD2 PROTEIN, HUMAN; TOLL LIKE RECEPTOR; VITAMIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; NOD2 GENE; PROTEIN DEGRADATION; PROTEIN INDUCTION; PROTEIN POLYMORPHISM; SCHOOL CHILD; SIGNAL TRANSDUCTION; CELL CULTURE; DENDRITIC CELL; GENETICS; IMMUNOLOGY; MUTATION; PATHOLOGY;

CALCITRIOL; CELLS, CULTURED; CROHN DISEASE; CYTOKINES; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; TOLL-LIKE RECEPTORS; VITAMINS;

EID: 84908203022     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2014.30     Document Type: Article

References (50)

1. Saleh,M. & Elson, C. O. Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity 34, 293-302 (2011).
2. Kaser, A., Zeissig, S. & Blumberg, R. S. Inflammatory bowel disease. Annu. Rev. Immunol. 28, 573-621 (2010).
3. Rai, E. & Wakeland, E. K. Genetic predispositions to autoimmunity-what have we learned? Semin. Immunol. 23, 67-83 (2011).
4. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012).
5. Franke, A. et al. Genome-widemeta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42, 1118-1125 (2010).
6. Khor, B., Gardet, A. & Xavier, R. J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307-317 (2011).
7. Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
8. Bonen, D. K. et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharides and peptidoglycan. Gastroenterology 124, 140-146 (2003).
9. Van Heel, D. A. et al. Muramyl dipeptide and Toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 365, 1794-1796 (2005).
10. Noguchi, E., Homma, Y., Kang, X., Netea, M. G. & Ma, X. A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1. Nat. Immunol. 10, 471-479 (2009).
11. Voss, E., Wehkamp, J., Wehkamp, K., Stange, E. F., Schroder, J. M. & Harder, J. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J. Biol. Chem. 281, 2005-2011 (2006).
12. Wang, T. T. et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin b2 innate immune pathway defective in Crohn Disease. J. Biol. Chem. 285, 2227-2231 (2010).
13. Travassos, L. H. et al. NOD1 and NOD2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 11, 55-62 (2009).
14. Cooney, R. et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med. 16, 90-97 (2010).
15. Homer, C. R., Richmond, A. L., Rebert, N. A., Achkar, J. P. & McDonald, C. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology 139, 1630-1641 (2010).
16. Molodecky, N. A. & Kaplan, G. C. Environmental risk factors for inflammatory bowel disease. Gastroenterol. Hepatol. 5, 339-346 (2010).
17. Logan, I. & Bowlus, C. L. The geoepidemiology of autoimmune intestinal diseases. Autoimmun. Rev. 9, A372-A378 (2010).
18. Khalili, H. et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut 61, 1686-1692 (2012).
19. Garg, M., Lubel, J. S., Sparrow, M. P., Holt, S. G. & Gibson, P. R. Review article: vitamin D and inflammatory bowel disease-established concepts and future directions. Aliment. Pharmacol. Ther. 36, 324-344 (2012).
20. Pappa, H. M. et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 118, 1950-1961 (2006).
21. Ananthakrishnan, A. N. et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 142, 482-489 (2012).
22. Nicholson, I., Dalzell, A. M. & El-Matary,W. Vitamin Das a therapy for colitis: a systematic review. J. Crohn's Colitis 6, 405-411 (2012).
23. Jorgensen, S. P. et al. Clinical trial: vitamin D3 treatment in Crohn's disease-a randomized double-blind placebo-controlled study. Aliment. Pharmacol. Ther. 32, 377-383 (2010).
24. Froicu, M., Weaver, V., Wynn, T. A., McDowell, M. A., Welsh, J. E. & Cantorna, M. T. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 17, 2386-2392 (2003).
25. Liu, N. et al. Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology 149, 4799-4808 (2008).
26. Cantorna, M. T., Munsick, C., Berniss, C. & Mahon, B. D. 1,25-dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr. 130, 2648-2652 (2000).
27. Daniel, C., Sartory, N. A., Zahn, N., Radeke, H. & Stein, J. M. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitrol is associated with change of a T Helper (Th) 1/Th17 to a Th2 and Regulatory T cell profile. J. Pharmacol. Exp. Ther. 324, 23-33 (2008).
28. Hewison, M. Vitamin D and the immune system: new perspectives on an old theme. Rheum. Dis. Clin. North Am. 38, 125-139 (2012).
29. Peelen, E. et al. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun. Rev. 10, 733-743 (2011).
30. Gynther, P., Toropainen, S., Matilainen, J. M., Seuter, S., Carlberg, C. & Vä isä nen, S. Mechanism of 1a,25-dihydroxyvitamin D(3)-dependent repression of interleukin-12B. Biochim. Biophys. Acta 1813, 810-818 (2011).
31. Lim,W.-C., Hanauer, S. B. & Li, Y. C. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 2, 308-315 (2005).
32. Smith, A. M. et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J. Exp. Med. 206, 1882-1887 (2009).
33. Seidelin, J. B., Broom, O. J., Olsen, J. &Nielsen, O. H. Evidence for impaired CARD15 signaling in Crohn's disease without disease linked variants. PLoS One 4, e7794 (2009).
34. Chang, S. H., Chung, Y. & Dong, C. Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. J. Biol. Chem. 285, 38751-38755 (2010).
35. Joshi, S. et al. 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol. Cell. Biol. 31, 3653-3669 (2011).
36. Yuk, J. M. et al. Vitamin D3 induces autophagy in human monocytes/ macrophages via cathelicidin. Cell Host Microbe 6, 231-243 (2009).
37. Schwalfenberg, G. K. Solar radiation and vitamin D: mitigating environmental factors in autoimmune disease. J. Environ. Public Health 2012, ID619381; doi:10. 1155/2012/619381 (2012).
38. Antico, A., Tampoia, M., Tozzoli, R. & Bizzaro, N. Can supplementationwith vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun. Rev. 12, 127-136 (2012).
39. Sadeghi, K. et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur. J. Immunol. 36, 361-370 (2006).
40. Khoo, A. L. et al. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin. Exp. Immunol. 164, 72-79 (2011).
41. Stio, M. et al. Interaction among vitamin D(3) analogue KH 1060, TNFalpha, and vitamin D receptor protein in peripheral blood mononuclear cells of inflammatory bowel disease patients. Int. Immunopharmacol. 6, 1083-1092 (2006).
42. Trinchieri, G. & Sher, A. Cooperation of Toll-like receptor signals in innate immune defense. Nat. Rev. Immunol. 7, 179-190 (2007).
43. Li, J. et al. Regulation of IL-8 and Il-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum. Mol. Genet. 13, 1715-1725 (2004).
44. van Heel, D. A. et al. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. Gut 54, 1553-1557 (2005).
45. Beynon, V. et al. NOD2/CARD15 genotype influences MDP-induced cytokine release and basal IL-12p40 levels in primary isolated peripheral blood monocytes. Inflamm. Bowel Dis. 14, 1033-1040 (2008).
46. Kramer, M., Netea, M. G., de Jong, D. J., Kullberg, B. J. & Adema, G. J. Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation. J. Leukoc. Biol. 79, 860-866 (2006).
47. Yazdanyar, S. & Weischer,M. Nordestgaard. Genotyping for NOD2 genetic variants and Crohn's disease: ameta-analysis. Clin. Chem. 55, 1950-1957 (2009).
48. Salucci, V. et al. Monocyte-derived dendritic cells from Crohn patients show differential NOD2/CARD15-dependent immune responses to bacteria. Inflamm. Bowel Dis. 14, 812-818 (2008).
49. Peeters, H. et al. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease. Int. J. Immunogenet. 34, 181-191 (2007).
50. Amre, D. et al. Autophagy gene ATG16L1 but not IRGM is associated with Crohn's disease in Canadian children. Inflamm Bowel Dis 15, 501-507 (2009).